| Ident. | Authors (with country if any) | Title |
|---|
| 000032 (2020) |
Ming Niu [République populaire de Chine] ; Rui-Lin Wang [République populaire de Chine] ; Zhong-Xia Wang [République populaire de Chine] ; Ping Zhang [République populaire de Chine] ; Zhao-Fang Bai [République populaire de Chine] ; Jing Jing [République populaire de Chine] ; Yu-Ming Guo [République populaire de Chine] ; Xu Zhao [République populaire de Chine] ; Xiao-Yan Zhan [République populaire de Chine] ; Zi-Teng Zhang [République populaire de Chine] ; Xue-Ai Song [République populaire de Chine] ; En-Qiang Qin [République populaire de Chine] ; Jia-Bo Wang [République populaire de Chine] ; Xiao-He Xiao [République populaire de Chine] | [Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking]. |
| 000046 (2020) |
E. Davenne [Belgique] ; J B Giot [Belgique] ; P. Huynen [Belgique] | [Coronavirus and COVID-19 : focus on a galopping pandemic]. |
| 000099 (2020) |
Yong Xiong [République populaire de Chine] ; Yuan Liu [République populaire de Chine] ; Liu Cao [République populaire de Chine] ; Dehe Wang [République populaire de Chine] ; Ming Guo [République populaire de Chine] ; Ao Jiang [République populaire de Chine] ; Dong Guo [République populaire de Chine] ; Wenjia Hu [République populaire de Chine] ; Jiayi Yang [République populaire de Chine] ; Zhidong Tang [République populaire de Chine] ; Honglong Wu [République populaire de Chine] ; Yongquan Lin [République populaire de Chine] ; Meiyuan Zhang [République populaire de Chine] ; Qi Zhang [République populaire de Chine] ; Mang Shi [République populaire de Chine] ; Yingle Liu [République populaire de Chine] ; Yu Zhou [République populaire de Chine] ; Ke Lan [République populaire de Chine] ; Yu Chen [République populaire de Chine] | Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. |
| 000131 (2020) |
Domenico Benvenuto [Italie] ; Marta Giovanetti [Brésil] ; Marco Salemi [États-Unis] ; Mattia Prosperi [États-Unis] ; Cecilia De Flora [Italie] ; Luiz Carlos Junior Alcantara [Brésil] ; Silvia Angeletti [Italie] ; Massimo Ciccozzi [Brésil] | The global spread of 2019-nCoV: a molecular evolutionary analysis |
| 000178 (2020) |
Domenico Benvenuto [Italie] ; Marta Giovanetti [Brésil] ; Alessandra Ciccozzi [Italie] ; Silvia Spoto [Italie] ; Silvia Angeletti [Italie] ; Massimo Ciccozzi [Brésil] | The 2019-new coronavirus epidemic: Evidence for virus evolution. |
| 000200 (2020) |
Yun Chen [République populaire de Chine] ; Yao Guo [République populaire de Chine] ; Yihang Pan [République populaire de Chine] ; Zhizhuang Joe Zhao [République populaire de Chine, États-Unis] | Structure analysis of the receptor binding of 2019-nCoV |
| 000202 (2020) |
Mushtaq Hussain [Pakistan] ; Nusrat Jabeen [Pakistan] ; Fozia Raza [Pakistan] ; Sanya Shabbir [Pakistan] ; Ayesha A. Baig [Pakistan] ; Anusha Amanullah [Pakistan] ; Basma Aziz [Pakistan] | Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein. |
| 000205 (2020) |
Jacques Fantini [France] ; Coralie Di Scala [France] ; Henri Chahinian [France] ; Nouara Yahi [France] | Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. |
| 000207 (2020) |
Suhas Srinivasan [États-Unis] ; Hongzhu Cui [États-Unis] ; Ziyang Gao [États-Unis] ; Ming Liu [États-Unis] ; Senbao Lu [États-Unis] ; Winnie Mkandawire [États-Unis] ; Oleksandr Narykov [États-Unis] ; Mo Sun [États-Unis] ; Dmitry Korkin [États-Unis] | Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins. |
| 000230 (2020) |
Gerard Kian-Meng Goh [Singapour] ; A. Keith Dunker [États-Unis] ; James A. Foster [États-Unis] ; Vladimir N. Uversky [États-Unis, Russie] | Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids |
| 000236 (2020) |
Nisreen M A. Okba ; Marcel A. Müller ; Wentao Li ; Chunyan Wang ; Corine H. Geurtsvankessel ; Victor M. Corman ; Mart M. Lamers ; Reina S. Sikkema ; Erwin De Bruin ; Felicity D. Chandler ; Yazdan Yazdanpanah ; Quentin Le Hingrat ; Diane Descamps ; Nadhira Houhou-Fidouh ; Chantal B E M. Reusken ; Berend-Jan Bosch ; Christian Drosten ; Marion P G. Koopmans ; Bart L. Haagmans | Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients. |
| 000245 (2020) |
Anu Haveri [Finlande] ; Teemu Smura [Finlande] ; Suvi Kuivanen [Finlande] ; Pamela Österlund [Finlande] ; Jussi Hepojoki [Suisse] ; Niina Ikonen [Finlande] ; Marjaana Pitk Paasi [Finlande] ; Soile Blomqvist [Finlande] ; Esa Rönkkö [Finlande] ; Anu Kantele [Finlande] ; Tomas Strandin [Finlande] ; Hannimari Kallio-Kokko [Finlande] ; Laura Mannonen [Finlande] ; Maija Lappalainen [Finlande] ; Markku Broas [Finlande] ; Miao Jiang [Finlande] ; Lotta Siira [Finlande] ; Mika Salminen [Finlande] ; Taneli Puumalainen [Finlande] ; Jussi Sane [Finlande] ; Merit Melin [Finlande] ; Olli Vapalahti [Finlande] ; Carita Savolainen-Kopra [Finlande] | Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020. |
| 000272 (2020) |
Firas A. Rabi [Jordanie] ; Mazhar S. Al Zoubi [Jordanie] ; Ghena A. Kasasbeh [Jordanie] ; Dunia M. Salameh [Jordanie] ; Amjad D. Al-Nasser [Jordanie] | SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far. |
| 000297 (2020) |
Abdo A. Elfiky | Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study |
| 000332 (2020) |
Minzhe Shen ; Ying Zhou ; Jiawei Ye ; Abdu Ahmed Abdullah Al-Maskri ; Yu Kang ; Su Zeng ; Sheng Cai | Recent advances and perspectives of nucleic acid detection for coronavirus |
| 000380 (2020) |
Yu Wai Chen [Hong Kong] ; Chin-Pang Bennu Yiu [Hong Kong] ; Kwok-Yin Wong [Hong Kong] | Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL
pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates |
| 000387 (2020) |
Farid Rahimi [Australie] ; Amin Talebi Bezmin Abadi [Iran] | Practical Strategies Against the Novel Coronavirus and COVID-19-the Imminent Global Threat. |
| 000450 (2020) |
Subramanian Boopathi [Chili] ; Adolfo B. Poma [Pologne] ; Ponmalai Kolandaivel [Inde] | Novel 2019 Coronavirus Structure, Mechanism of Action, Antiviral drug promises and rule out against its treatment. |
| 000458 (2020) |
Shengwei Yu [République populaire de Chine] ; Junwu Wang [République populaire de Chine] ; Haitao Shen [République populaire de Chine] | Network pharmacology-based analysis of the role of traditional Chinese herbal medicines in the treatment of COVID-19. |
| 000467 (2020) |
I. Aanouz [Maroc] ; A. Belhassan [Maroc] ; K. El Khatabi [Maroc] ; T. Lakhlifi [Maroc] ; M. El Idrissi [Maroc] ; M. Bouachrine [Maroc] | Moroccan Medicinal plants as inhibitors of COVID-19: Computational investigations. |
| 000468 (2020) |
Xiaowei Li [République populaire de Chine] ; Manman Geng [République populaire de Chine] ; Yizhao Peng [République populaire de Chine] ; Liesu Meng [République populaire de Chine] ; Shemin Lu [République populaire de Chine] | Molecular immune pathogenesis and diagnosis of COVID-19 |
